Insights

Innovative Therapeutics MacroGenics specializes in next-generation antibody-based cancer treatments, demonstrating a strong focus on innovative medicines that could expand partnerships with biotech and pharmaceutical companies seeking cutting-edge oncology solutions.

Recent Leadership Changes The promotion of Eric Risser to CEO and his active participation in major industry conferences indicate a strategic leadership shift, presenting opportunities for relationship-building around corporate initiatives and future pipeline developments.

Product Launches Having successfully launched its first commercial product, Margenza, in 2021, MacroGenics shows a capacity for product commercialization, which suggests potential collaboration or support services in manufacturing, distribution, or sales channels.

Funding and Revenue With a revenue range of 50 to 100 million dollars and significant funding of 110 million dollars, MacroGenics is well-positioned for pipeline expansion, offering opportunities to provide complementary services such as clinical research support or strategic partnerships.

Industry Engagement Active participation in multiple major healthcare conferences signals a commitment to industry visibility and networking, creating pathways for engaging with key stakeholders, potential collaborators, and new market opportunities through event sponsorships or strategic outreach.

Similar companies to MacroGenics, Inc.

MacroGenics, Inc. Tech Stack

MacroGenics, Inc. uses 8 technology products and services including SAS, Akamai, SQL, and more. Explore MacroGenics, Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Akamai
    Content Delivery Network
  • SQL
    Database
  • Apple iCloud Mail
    Email
  • Workiva
    Governance, Risk And Compliance
  • Influence Health
    Healthcare Marketing
  • Okta
    Identity Verification
  • Google Analytics
    Web Analytics

Media & News

MacroGenics, Inc.'s Email Address Formats

MacroGenics, Inc. uses at least 1 format(s):
MacroGenics, Inc. Email FormatsExamplePercentage
LastF@macrogenics.comDoeJ@macrogenics.com
82%
Last@macrogenics.comDoe@macrogenics.com
8%
FirstL@macrogenics.comJohnD@macrogenics.com
6%
FLast@macrogenics.comJDoe@macrogenics.com
4%

Frequently Asked Questions

Where is MacroGenics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
MacroGenics, Inc.'s main headquarters is located at 9704 Medical Center Drive, Rockville, MD 20850, US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is MacroGenics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact MacroGenics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MacroGenics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
MacroGenics, Inc. is a publicly traded company; the company's stock symbol is MGNX.

What is MacroGenics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
MacroGenics, Inc.'s official website is macrogenics.com and has social profiles on LinkedInCrunchbase.

How much revenue does MacroGenics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2025, MacroGenics, Inc.'s annual revenue is estimated to be $101M.

What is MacroGenics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
MacroGenics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MacroGenics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, MacroGenics, Inc. has approximately 391 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: E. R.Chief Scientific Officer: E. B.Chief Medical Officer And Senior Vice-President, Clinical Development: J. W.. Explore MacroGenics, Inc.'s employee directory with LeadIQ.

What industry does MacroGenics, Inc. belong to?

Minus sign iconPlus sign icon
MacroGenics, Inc. operates in the Biotechnology Research industry.

What technology does MacroGenics, Inc. use?

Minus sign iconPlus sign icon
MacroGenics, Inc.'s tech stack includes SASAkamaiSQLApple iCloud MailWorkivaInfluence HealthOktaGoogle Analytics.

What is MacroGenics, Inc.'s email format?

Minus sign iconPlus sign icon
MacroGenics, Inc.'s email format typically follows the pattern of LastF@macrogenics.com. Find more MacroGenics, Inc. email formats with LeadIQ.

How much funding has MacroGenics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2025, MacroGenics, Inc. has raised $110M in funding. The last funding round occurred on Feb 12, 2019 for $110M.

When was MacroGenics, Inc. founded?

Minus sign iconPlus sign icon
MacroGenics, Inc. was founded in 2000.

MacroGenics, Inc.

Biotechnology ResearchUnited States201-500 Employees

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies.  Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. 
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.

Section iconCompany Overview

Headquarters
9704 Medical Center Drive, Rockville, MD 20850, US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MGNX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
201-500

Section iconFunding & Financials

  • $110M

    MacroGenics, Inc. has raised a total of $110M of funding over 10 rounds. Their latest funding round was raised on Feb 12, 2019 in the amount of $110M.

  • $50M$100M

    MacroGenics, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $110M

    MacroGenics, Inc. has raised a total of $110M of funding over 10 rounds. Their latest funding round was raised on Feb 12, 2019 in the amount of $110M.

  • $50M$100M

    MacroGenics, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.